US Edition
MTTI Appoints Veteran Radiopharmaceutical Leader Dr. Danielle Meyrick as Chief Medical Officer
Summary by MyChesCo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
MTTI Appoints Veteran Radiopharmaceutical Leader Dr. Danielle Meyrick as Chief Medical Officer
WEST CHESTER, PA — Molecular Targeting Technologies, Inc. (MTTI) has named Dr. Danielle Meyrick as its new Chief Medical Officer, strengthening its leadership team as it pushes forward with the development of its targeted radiotherapeutic (TRT) pipeline. A seasoned medical executive, Dr. Meyrick brings over two decades of experience in cancer research and TRT development. She has previously served in senior leadership roles at Telix Pharmaceutic…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
